Skip to Main Content

Paper Details

Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma" by Giovanni Barosi and Robert Peter Gale.
Leukemia
2
2019

Datasets

Release 1.2